Portal de Periódicos da CAPES

An Open-Label, Phase I, Dose-Escalation Study of Tumor Necrosis Factor-α (TNFerade™ Biologic) Gene Transfer with Radiation Therapy for Locally Advanced, Recurrent, or Metastatic Solid Tumors

2001; Mary Ann Liebert, Inc.; Volume: 12; Issue: 9 Linguagem: Inglês

10.1089/104303401750214320

1557-7422

Anand Sharma, Sridhar Mani, Nader Hanna, Chandan Guha, Bhadrasain Vikram, Ralph R. Weichselbaum, J. A. Sparano, Brij Sood, Dong Ho Lee, William F. Regine, M Muhodin, Joseph Valentino, J Herman, Paolo De Simone, Sarah Arnold, Justin Carrico, Anna K. Rockich, J Warner-Carpenter, Marietta Barton-Baxter,

RNA Interference and Gene Delivery

Human Gene TherapyVol. 12, No. 9 Clinical ProtocolsAn Open-Label, Phase I, Dose-Escalation Study of Tumor Necrosis Factor-α (TNFerade™ Biologic) Gene Transfer with Radiation Therapy for Locally Advanced, Recurrent, or Metastatic Solid TumorsPublished Online:6 Jul 2004https://doi.org/10.1089/104303401750214320AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byRadiotherapy in Combination With Cytokine Treatment22 May 2019 | Frontiers in Oncology, Vol. 9A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiationAnnals of Oncology, Vol. 24, No. 3Endoscopic Ultrasound-Guided Oncologic Therapy for Pancreatic CancerDiagnostic and Therapeutic Endoscopy, Vol. 2013Cancer gene therapy targeting cellular apoptosis machineryCancer Treatment Reviews, Vol. 38, No. 7Molecular Targeted TherapyA Pilot Feasibility Study of TNFerade™ Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal CancerOncology, Vol. 79, No. 5-6Enhancing Radiotherapy With Genetically Engineered VirusesJournal of Clinical Oncology, Vol. 25, No. 26Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delayJournal of Controlled Release, Vol. 99, No. 3Chemoinducible gene therapy: A strategy to enhance doxorubicin antitumor activity14 September 2004 | Molecular Cancer Therapeutics, Vol. 3, No. 9Enhancement of Radiation Response with TNF/TRAILCombination of Gene Therapy with Radiation Volume 12Issue 9Jun 2001 To cite this article:An Open-Label, Phase I, Dose-Escalation Study of Tumor Necrosis Factor-α (TNFerade™ Biologic) Gene Transfer with Radiation Therapy for Locally Advanced, Recurrent, or Metastatic Solid Tumors.Human Gene Therapy.Jun 2001.1109-1131.http://doi.org/10.1089/104303401750214320Published in Volume: 12 Issue 9: July 6, 2004PDF download